AMENDMENT No. 1, dated as of October 25, 2016 (this “Amendment”), to the Credit Agreement, dated as of May 7, 2015, by and among Horizon Pharma, Inc., a Delaware corporation (“Horizon” or the “Borrower”), Horizon Pharma Public Limited Company, an...Credit Agreement • October 25th, 2016 • Horizon Pharma PLC • Pharmaceutical preparations • Delaware
CREDIT AGREEMENT (this “Agreement”) dated as of May 7, 2015, (as amended by Amendment No. 1, dated October 25, 2016, this “Agreement”), among HORIZON PHARMA, INC., a Delaware corporation (“Horizon” or the “Borrower”), HORIZON PHARMA PUBLIC LIMITED COMPANY, an Irish public limited company (“Irish Holdco”), the Subsidiary Guarantors (as such term is defined in Article I) party hereto, the LENDERS from time to time party hereto and CITIBANK, N.A., as Administrative Agent and Collateral Agent.
HORIZON PHARMA, INC. and HORIZON PHARMA USA, INC. 8.750% SENIOR NOTES DUE 2024 INDENTURE Dated as of October 25, 2016 U.S. BANK NATIONAL ASSOCIATION, as TrusteeHorizon Pharma • October 25th, 2016 • Horizon Pharma PLC • Pharmaceutical preparations • New York
INDENTURE dated as of October 25 2016 among HORIZON PHARMA, INC., a Delaware corporation, HORIZON PHARMA USA, INC., a Delaware corporation, the Guarantors from time to time party hereto and U.S. BANK NATIONAL ASSOCIATION, a national banking association, as trustee (the “Trustee”).
